HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsuro Otsuka Selected Research

Hemoglobins (Hemoglobin)

9/2022Clinical parameters among patients in Japan with anemia and non-dialysis-dependent chronic kidney disease with and without diabetes mellitus who received roxadustat.
1/2021Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsuro Otsuka Research Topics

Disease

7Anemia
09/2022 - 01/2019
7Hypoxia (Hypoxemia)
09/2022 - 01/2019
7Chronic Renal Insufficiency
09/2022 - 01/2019
1Diabetes Mellitus
09/2022
1Retinal Hemorrhage
04/2022
1Inflammation (Inflammations)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019

Drug/Important Bio-Agent (IBA)

7roxadustatIBA
09/2022 - 01/2019
7Prolyl-Hydroxylase InhibitorsIBA
09/2022 - 01/2019
2Hemoglobins (Hemoglobin)IBA
09/2022 - 01/2021
2HematinicsIBA
04/2020 - 01/2020
1Darbepoetin alfa (Aranesp)FDA Link
01/2021
1IronIBA
01/2020

Therapy/Procedure

1Peritoneal Dialysis
04/2020